The efficacy of liraglutide (a GLP-1 receptor agonist) in treating DSS-induced colitis and its accompanying Paneth cell metaplasia was examined and correlated to its impact on the levels of colonic autophagy. This evidence concerns the gene GLP1R and colitis.